Over the last two decades, great progress has been made in treating cancer.
The two main areas of focus remain making cancer treatment more effective and less toxic.
With our focus on complex biologics, we aim to widen the therapeutic window of cancer treatments, making them more effective and better tolerated.
Our approaches include combining biologically active proteins, activating the immune system against cancer-specific targets, and delivering anti-cancer agents directly and specifically to tumors.
Please return to our website in the future to check for updates on our cancer-targeted therapies in development